Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score.

Autor: Herr MM; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Electronic address: Megan.Herr@RoswellPark.org., Chen GL; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ross M; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Jacobson H; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., McKenzie R; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Markel L; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Balderman SR; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Ho CM; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Hahn T; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York., McCarthy PL; Transplant and Cellular Therapy Program, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Nov; Vol. 26 (11), pp. e271-e274. Date of Electronic Publication: 2020 Jul 29.

Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.

Autor: Herr MM; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Torka P; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Zhang Y; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Wallace PK; Department of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Tario JD Jr; Department of Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Repasky EA; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Chen GL; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ho CM; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Balderman SR; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Ross M; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Paiva B; Clínica Universidad de Navarra, Pamplona, Spain., Hernandez-Ilizaliturri FJ; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., McCarthy PL; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Hahn T; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Theresa.hahn@roswellpark.org.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2020 Jan; Vol. 55 (1), pp. 272.

Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.

Autor: Balderman SR; Division of Hematology/Oncology, Department of Medicine., Li AJ; Department of Pathology and Laboratory Medicine., Hoffman CM; Department of Pharmacology and Physiology, and., Frisch BJ; Division of Hematology/Oncology, Department of Medicine., Goodman AN; Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY., LaMere MW; Division of Hematology/Oncology, Department of Medicine., Georger MA; Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY., Evans AG; Department of Pathology and Laboratory Medicine., Liesveld JL; Division of Hematology/Oncology, Department of Medicine., Becker MW; Division of Hematology/Oncology, Department of Medicine., Calvi LM; Division of Endocrinology and Metabolism, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY.

Publikováno v: Blood [Blood] 2016 Feb 04; Vol. 127 (5), pp. 616-25. Date of Electronic Publication: 2015 Dec 04.

Unusual Manifestations of Monoclonal Gammopathy: I. Ocular Disease.

Autor: Balderman SR; Instructor in Medicine, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA., Lichtman MA; Professor of Medicine and of Biochemistry and Biophysics, James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA.

Publikováno v: Rambam Maimonides medical journal [Rambam Maimonides Med J] 2015 Jul 30; Vol. 6 (3). Date of Electronic Publication: 2015 Jul 30.